Losartan in diabetic nephropathy
Author:
Publisher
Informa UK Limited
Subject
Cardiology and Cardiovascular Medicine,General Medicine,Internal Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1586/14779072.2.4.473
Reference94 articles.
1. Forecast of the Number of Patients with End-Stage Renal Disease in the United States to the Year 2010
2. Maintenance Dialysis Population Dynamics: Current Trends and Long-Term Implications
3. The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient?
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Losartan ameliorates renal fibrosis by inhibiting tumor necrosis factor signal pathway;Nefrología (English Edition);2024-03
2. Development, optimization, and assessment of losartan nano-bilosomes to mitigate diabetes-induced microvascular complications in Sprague Dawley rats;Journal of Drug Delivery Science and Technology;2024-02
3. Losartan ameliorates renal fibrosis by inhibiting tumor necrosis factor signal pathway;Nefrología;2023-09
4. The Qi-Bang-Yi-Shen formula ameliorates renal dysfunction and fibrosis in rats with diabetic kidney disease <em>via</em> regulating PI3K/AKT, ERK and PPARγ signaling pathways;European Journal of Histochemistry;2023-03-01
5. Pentosan polysulfate exerts anti‐inflammatory effect and halts albuminuria progression in diabetic nephropathy: Role of combined losartan;Fundamental & Clinical Pharmacology;2022-05-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3